NAT10 and lung cancer: While pre-treatment high neutrophil/lymphocyte ratio (NLR), high pan-immune inflammation value (PIIV), and high systemic inflammation response index (SIRI) were associated with high advanced lung cancer inflammation index (ALI), a high HALP score has been found to be associated with favourable survival [14].